全球多模態成像市場

到 2030 年，全球多模態成像市場規模將達到 35 億美元

2024 年全球多模態成像市場規模估計為 28 億美元，預計到 2030 年將達到 35 億美元，2024 年至 2030 年的複合年成長率為 4.0%。 PET/CT 系統是報告中分析的細分市場之一，預計複合年成長率為 4.8%，到分析期結束時將達到 13 億美元。在分析期內，SPECT/CT 系統部分預計將以 3.0% 的複合年成長率成長。

美國市場規模估計為 7.234 億美元，中國市場預計複合年成長率為 6.6%

預計 2024 年美國多模態成像市場價值將達到 7.234 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 7.647 億美元，2024-2030 年分析期間的複合年成長率為 6.6%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 2.2% 和 3.1%。在歐洲，德國的複合年成長率預計為 2.7%。

全球多模態成像市場 - 主要趨勢與促進因素摘要

多模態成像將如何徹底改變診斷？

多模態成像結合了不同的顯像模式，提供有關組織和器官的更全面的資訊。這種方法透過整合每種方式的優勢來提高診斷的準確性，例如將 MRI 的解剖細節與 PET 和電腦斷層掃描的功能資料相結合。該技術廣泛應用於腫瘤學中的腫瘤檢測和監測、神經病學中的腦部映射以及循環系統的心臟功能評估。該技術為臨床醫生提供了單模態成像無法獲得的見解，例如將解剖結構與代謝活動相關聯，這對於早期疾病檢測和治療計劃至關重要。隨著影像技術的進步，多模態影像不再侷限於臨床診斷，而是擴展到研發、藥物開發等領域。它正應用於臨床前試驗，以更好地了解疾病機制和評估新治療方法的療效。多模態影像能夠融合來自不同來源的資料，這使其成為需要更詳細、更全面地了解患者病情的複雜病例的重要工具。該技術還支持個人化醫療，可根據患者的疾病特徵制定個人化治療方案。

哪些趨勢正在影響多模態成像市場？

推動多模態影像廣泛應用的趨勢包括慢性病的增加、診斷影像模式的技術進步以及對精準醫療的日益關注。癌症、心血管疾病和神經系統疾病等慢性疾病的增加推動了對精準診斷工具的需求，從而推動了對多模態成像的需求。人工智慧和機器學習在影像處理中的整合進一步增強了多模態成像的能力，實現了自動影像分析和更準確的診斷。還有一種趨勢是將多種模式整合到單一設備中的混合影像診斷系統，例如 PET/CT 和 PET/MRI 掃描儀。這些系統提供全面的診斷資料，從而實現更快、更有效率的臨床工作流程。在研究中，它們擴大被用於研究疾病進展和評估治療的效果。此外，政府對醫療保健研究和開發的資助和津貼正在刺激醫院和研究機構採用先進的影像技術。

每個部分對多模態成像市場有何影響？

模式部分包括 PET/CT、PET/MRI、SPECT/CT 和其他組合。 PET/CT 佔據最大的市場佔有率，因為它廣泛用於腫瘤學中的腫瘤檢測和治療監測。 PET/MRI 也越來越受歡迎，尤其是在神經病學和小兒科，因為它可以在限制輻射暴露的同時提供功能和結構資訊。根據應用，市場分為腫瘤學、循環系統、神經病學和其他領域，其中腫瘤學是最大的細分市場。多模態影像的最終使用者包括醫院、診斷影像中心和研究機構。由於醫院執行大量的診斷影像程序，因此醫院在市場上佔據主導地位。從區域來看，北美引領市場，得益於先進的醫療保健基礎設施和新技術的高度採用。其次是歐洲，該地區在醫療保健和研究方面投入了大量資金，而亞太地區則由於醫療成本的上升和醫學影像處理應用的不斷擴大而經歷快速成長。

哪些因素推動了多模態成像市場的成長？

多模態影像市場的成長受到多種因素的推動，例如慢性病盛行率上升、診斷影像模式的技術進步以及醫療保健基礎設施的投資增加。對癌症、心血管和神經系統疾病的精準診斷工具的需求正在推動多模態影像的採用。將人工智慧融入影像處理軟體等技術創新進一步提高了診斷的準確性，並支持了市場成長。此外，精準醫療和個人化治療計劃的趨勢正在推動使用多模態影像來提供全面的資料來指導治療決策。

部分

技術（PET/CT 系統、SPECT/CT 系統、PET/MR 系統、OCT/眼底影像系統、其他技術）、應用（腫瘤學、心臟病學、神經病學、眼科學、其他應用）、最終用途（醫院、診斷影像中心、其他最終用途）

受訪企業範例（共42家）

• Canon Medical Systems Corporation
• Carl Zeiss AG
• GE Healthcare
• Heidelberg Engineering
• Infraredx, Inc.
• Koninklijke Philips NV
• Mediso Medical Imaging Kft
• MILabs BV
• Neusoft Medical Systems Co., Ltd.
• Northridge Tri-Modality Imaging, Inc.
• PerkinElmer, Inc.
• Shanghai United Imaging Healthcare Co., Ltd.
• Siemens Healthineers
• Spectrum Dynamics Medical
• Topcon Corporation
• United Imaging Healthcare Co., Ltd.

目錄

第1章調查方法

第 2 章執行摘要

• 市場概況
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章 市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲國家
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Multimodal Imaging Market to Reach US$3.5 Billion by 2030

The global market for Multimodal Imaging estimated at US$2.8 Billion in the year 2024, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. PET / CT Systems, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the SPECT / CT Systems segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$723.4 Million While China is Forecast to Grow at 6.6% CAGR

The Multimodal Imaging market in the U.S. is estimated at US$723.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$764.7 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Multimodal Imaging Market - Key Trends and Drivers Summarized

How Is Multimodal Imaging Transforming Diagnostic Techniques?

Multimodal imaging combines different imaging modalities to provide more comprehensive information about tissues or organs. This approach enhances diagnostic accuracy by integrating the strengths of each modality, such as combining anatomical detail from MRI with functional data from PET or CT scans. It is used extensively in oncology for tumor detection and monitoring, neurology for brain mapping, and cardiology for evaluating heart function. The technology allows clinicians to gain insights that single-modal imaging cannot provide, such as correlating anatomical structures with metabolic activity, which is crucial for early disease detection and treatment planning. With advancements in imaging technologies, multimodal imaging is moving beyond clinical diagnostics to include areas such as research and drug development. It is being applied in preclinical studies to better understand disease mechanisms and assess the effectiveness of new therapies. Multimodal imaging's ability to fuse data from different sources makes it an essential tool for complex cases, where a more detailed and holistic view of the patient's condition is necessary. The technology also supports personalized medicine, allowing for tailored treatment plans based on the specific characteristics of a patient's disease.

What Trends Are Influencing the Multimodal Imaging Market?

Several trends are driving the adoption of multimodal imaging, including the growing prevalence of chronic diseases, technological advancements in imaging modalities, and the increasing focus on precision medicine. The rise in chronic conditions such as cancer, cardiovascular diseases, and neurological disorders has led to a greater need for accurate diagnostic tools, boosting the demand for multimodal imaging. The integration of AI and machine learning in image processing is further enhancing the capabilities of multimodal imaging, enabling automated image analysis and more precise diagnosis. There is also a trend towards hybrid imaging systems, which integrate multiple modalities in a single machine, such as PET/CT or PET/MRI scanners. These systems provide comprehensive diagnostic data, leading to faster and more efficient clinical workflows. In research, multimodal imaging is increasingly used for studying disease progression and evaluating treatment efficacy. Moreover, government funding and grants for healthcare research and development are facilitating the adoption of advanced imaging technologies in hospitals and research institutions.

How Do Segments Impact the Multimodal Imaging Market?

Modality segments include PET/CT, PET/MRI, SPECT/CT, and other combinations. PET/CT holds the largest market share due to its wide use in oncology for tumor detection and therapy monitoring. PET/MRI is also gaining popularity, especially in neurology and pediatrics, for its ability to provide both functional and structural information with reduced radiation exposure. The market is segmented by application into oncology, cardiology, neurology, and others, with oncology being the largest segment. End-users of multimodal imaging include hospitals, diagnostic imaging centers, and research institutions. Hospitals dominate the market due to the high volume of imaging procedures performed in these settings. Geographically, North America leads the market, driven by advanced healthcare infrastructure and high adoption rates of new technologies. Europe follows, with significant investments in healthcare and research, while the Asia-Pacific region is experiencing rapid growth due to increasing healthcare expenditure and expanding medical imaging applications.

What Factors Are Driving the Growth in the Multimodal Imaging Market?

The growth in the multimodal imaging market is driven by several factors, including the rising prevalence of chronic diseases, technological advancements in imaging modalities, and increasing investments in healthcare infrastructure. The demand for precise diagnostic tools for cancer, cardiovascular diseases, and neurological disorders is boosting the adoption of multimodal imaging. Technological innovations, such as the integration of AI in imaging software, are further enhancing diagnostic accuracy, supporting market growth. Moreover, the trend towards precision medicine and personalized treatment plans is driving the use of multimodal imaging, as it provides comprehensive data that can guide therapeutic decisions.

SCOPE OF STUDY:

The report analyzes the Multimodal Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems, Other Technologies); Application (Oncology, Cardiology, Brain & Neurology, Ophthalmology, Other Applications); End-Use (Hospitals, Diagnostic Imaging Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Canon Medical Systems Corporation
• Carl Zeiss AG
• GE Healthcare
• Heidelberg Engineering
• Infraredx, Inc.
• Koninklijke Philips N.V.
• Mediso Medical Imaging Kft
• MILabs B.V.
• Neusoft Medical Systems Co., Ltd.
• Northridge Tri-Modality Imaging, Inc.
• PerkinElmer, Inc.
• Shanghai United Imaging Healthcare Co., Ltd.
• Siemens Healthineers
• Spectrum Dynamics Medical
• Topcon Corporation
• United Imaging Healthcare Co., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Global Economic Update
  • Multimodal Imaging - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Accurate Diagnostic and Therapeutic Solutions Spurs Growth in Multimodal Imaging Market
  • Technological Advancements in Hybrid Imaging Techniques Strengthen Business Case for Adoption
  • Growing Focus on Early Disease Detection and Personalized Medicine Expands Addressable Market
  • Expansion of Multimodal Imaging in Neurology, Oncology, and Cardiology Fuels Market Growth
  • Increasing Adoption of Multimodal Imaging in Preclinical and Clinical Research Expands Market Opportunities
  • Technological Innovations in PET-MRI, SPECT-CT, and Optical Imaging Propel Market Expansion
  • Rising Focus on Enhancing Image Resolution and Reducing Scan Time Drives Demand for Multimodal Imaging
  • Growing Use of Multimodal Imaging in Surgical Planning and Image-Guided Interventions Expands Market Potential
  • Technological Advancements in Artificial Intelligence and Machine Learning for Image Analysis Propel Market Growth
  • Increasing Focus on Integrating Multimodal Imaging with Molecular and Functional Imaging Drives Adoption
  • Rising Demand for Multimodal Imaging in Pediatric, Geriatric, and Rare Disease Applications Strengthens Global Market
  • Expansion of Multimodal Imaging in Veterinary and Non-Human Biological Research Expands Market Opportunities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Multimodal Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Multimodal Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Multimodal Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Brain & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Brain & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Brain & Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 30: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 31: World Multimodal Imaging Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for PET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for PET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for PET / CT Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for SPECT / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for SPECT / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for SPECT / CT Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for PET / MR Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for PET / MR Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for PET / MR Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for OCT / Fundus Imaging Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for OCT / Fundus Imaging Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for OCT / Fundus Imaging Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Multimodal Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Multimodal Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Multimodal Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Multimodal Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Multimodal Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Multimodal Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Multimodal Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Multimodal Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Multimodal Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION